Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community' - 2Revealing the Incomparable Realms: An Excursion through Power and Inheritance
- 3The Best 20 Photography Instagram Records to Follow
- 4India’s delayed climate plan sets modest emission target
- 5I visited every country by 25. Antarctica showed me how much I still hadn't seen.
- FDA approves Wegovy pill for weight loss
- Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors
- NASA begins the countdown for humanity's first launch to the moon in 53 years
- Well known Tea Brands for Each Tea Sweetheart
- Federal judge upholds Hawaii's new climate change tax on cruise passengers
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- Support Your Investment funds with These Individual accounting Thoughts
- Factbox-China's crewed lunar programme eyes astronaut landing by 2030
- Step by step instructions to Analyze Senior Insurance Contracts Really.
